-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US4618741098 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 185M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | nan |
| Dividend Yield | None |
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EXOZ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025